β(3)-Adrenoceptor ligand development history through patent review.
about
Do we need anti-obesity drugs?Miglitol increases energy expenditure by upregulating uncoupling protein 1 of brown adipose tissue and reduces obesity in dietary-induced obese mice.Beta3-adrenergic receptors modulate vascular endothelial growth factor release in response to hypoxia through the nitric oxide pathway in mouse retinal explants.
P2860
β(3)-Adrenoceptor ligand development history through patent review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
β(3)-Adrenoceptor ligand development history through patent review.
@en
type
label
β(3)-Adrenoceptor ligand development history through patent review.
@en
prefLabel
β(3)-Adrenoceptor ligand development history through patent review.
@en
P2860
P1476
β(3)-Adrenoceptor ligand development history through patent review.
@en
P2860
P304
P356
10.1517/13543776.2011.561316
P407
P577
2011-03-17T00:00:00Z